Cart
sales@molnova.com
SB1317
CAS No. 1204918-72-8
SB1317( —— )
Catalog No. M17190 CAS No. 1204918-72-8
SB1317 is a potent inhibitor of cyclin dependant kinases (CDKs), Janus kinase 2 (JAK2), and Fms-like tyrosine kinase-3 (FLT3).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 29 | In Stock |
|
| 5MG | 46 | In Stock |
|
| 10MG | 79 | In Stock |
|
| 25MG | 158 | In Stock |
|
| 50MG | 263 | In Stock |
|
| 100MG | 451 | In Stock |
|
| 200MG | 644 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSB1317
-
NoteResearch use only, not for human use.
-
Brief DescriptionSB1317 is a potent inhibitor of cyclin dependant kinases (CDKs), Janus kinase 2 (JAK2), and Fms-like tyrosine kinase-3 (FLT3).
-
DescriptionSB1317 is a potent inhibitor of cyclin dependant kinases (CDKs), Janus kinase 2 (JAK2), and Fms-like tyrosine kinase-3 (FLT3).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
RecptorCDKs| FLT3| JAK2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1204918-72-8
-
Formula Weight372.46
-
Molecular FormulaC23H24N4O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (134.24 mM)
-
SMILESCN1C/C=C/CCOc2cccc(c2)c2nc(ncc2)Nc2cccc(c2)C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Poulsen A, et al. J Mol Model. 2013 Jan;19(1):119-30.
molnova catalog
related products
-
Zolmitriptan
Zolmitriptan is a selective serotonin receptor agonist.
-
GR 125743
GR 125743 is a novel antagonist of 5-HT1B/1D receptor.GR-125743, a new radiolabelled derivative of a compound that exhibits selective antagonistic properties with respect to the serotonin human (h5-HT1D) and human (h5-HT1B) receptors.?The compound has been characterized for its ability to label the cloned h5-HT1D and h5-HT1B receptors.?
-
Vortioxetine
Vortioxetine (Lu AA21004) is a multimodal serotonergic agent, inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT with IC50 of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively.
